October 16, 2017 | Israeli-based overactive bladder treatment startup Vensica Medical has raised $2 million in a round led by Minnesota-based urology and gynecology device proprietor Cogentix Medical. Cogentix will receive one seat on the Vensica board with options to acquire the entire company for an additional $8 million. Vensica Medical is a private preclinical startup in the process of developing a system to treat overactive bladder (an urgent need to urinate and involuntary loss of bladder control) by using a type of needle-free ultrasound device that will deliver Botox to the bladder using ultrasound technology. Vensica Medical was founded by Avner Geva in 2014.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments